Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-12-12
1986-05-27
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514355, 514909, A61K 3144
Patent
active
045915946
ABSTRACT:
The present disclosure relates to the use of thromboxane synthase inhibitors as antiobesity agents and insulin lowering agents. Such compounds fall into a variety of classes among which are 1-substituted imidazoles, 4-substituted imidazoles, 3-substituted pyridines, 3-substituted indoles, 4-substituted pyrimidines, 5-substituted tetrazoles, pyrazolidines, quinazolines, and substituted xanthene carboxylic acids.
REFERENCES:
patent: 4098908 (1978-07-01), Kathawala
Chem. Abst. 66: 103339j (1967)--Silvestrini.
Chem. Abst. 67: 18261(d) (1967)--Chmielowa et al.
Chem. Abst. 70: 104,175x (1969)--Lackova et al.
Chem. Abst. 86: 104,296t (1977)--Badilescu et al.
Chem. Abst. 101: 66403n (1984)--Coppes et al.
Hamilton James G.
Sullivan Ann C.
Tobias Lawrence D.
Triscari Joseph
Hoffmann-La Roche Inc.
Isgro William G.
Leon Bernard S.
Robinson Douglas W.
Saxe Jon S.
LandOfFree
Thromboxane synthase inhibitors as antiobesity agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thromboxane synthase inhibitors as antiobesity agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thromboxane synthase inhibitors as antiobesity agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1571245